Skip to content

Ocular Coil Drug Delivery Comfort Trial

Evaluation of the Safety and Tolerability of an Ocular Coil

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03488017
Acronym
OCDC
Enrollment
42
Registered
2018-04-04
Start date
2018-06-01
Completion date
2019-08-02
Last updated
2019-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Brief summary

The Ocular Coil is intended to provide drug delivery to the ocular surface. This study will evaluate the safety and tolerability of the placebo Ocular Coil in healthy subjects.

Detailed description

This study is designed to evaluate the safety and comfort of a placebo Ocular Coil for 28 days in 40 healthy subjects.

Interventions

DEVICEOcular Coil

Non-invasive ocular device

Sponsors

Maastricht University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Age between 18 and 75 years old * Informed and having given informed consent * Willing and able to comply with scheduled visits and other study procedures

Exclusion criteria

* Subjects with a history of eye disease that can make them vulnerable for irritation by the coil. * Subjects wearing contact lenses (unless they are willing to replace them for glasses for the duration of the study). * Subjects using eye drops (during the study). * Subjects with an Oriental/Asian lid crease, because of their narrow fornix. * Subjects who do not speak and/or write Dutch properly. * Subjects with a history of serious adverse reaction or hypersensitivity to components of the ocular coil. or to ophthalmic anaesthetics * Women who are pregnant or nursing their child, or have the intention to become pregnant during the course of the study.

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in terms of ocular irritation28 daysOcular irritation is assessed by slit lamp microscopy through evaluation of the ocular redness, inflammatory cells and flare.

Secondary

MeasureTime frameDescription
Total time of Ocular Coil retention28 daysThe total number of days that the Ocular Coil is worn by the participant (from placement until removal) is recorded.
Percentage of Participants in Each Response Category of Subject Comfort28 daysSubject comfort is assessed via a custom-made questionnaire. This questionnaire includes several questions related to eye comfort (itchy feeling, foreign feeling, etc.) and uses a 5-point scale (from agree to do not agree) and a 4-point scale (from always to never). The percentage of participants in each response category is recorded.
Incidence of ocular adverse events28 daysIncidence of ocular adverse events related to the Ocular Coil or the associated procedures (placement and removal) is evaluated.

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026